Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage ...

Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.

All doses of Novo Nordisk's popular GLP-1 medicines Ozempic and Wegovy are available in the U.S. and being regularly shipped to wholesalers, the drugmaker confirmed Wednesday. One dose form or another ...

Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now ...

Added Oct 28, 2024 at 09:07PM EDT by Mateus. On October 15th, 2024, American hip-hop artist Fat Joe admitted in an exclusive interview with US Weekly [1] that Ozempic, which he takes for diabetes, and ...

In a recent study, people with type 2 diabetes who took Ozempic appeared to lower their Alzheimer’s risk more than those using insulin. Ozempic was also linked to a greater reduction in ...

A 24-week trial shows up to 52% decrease in urinary protein and 30% reduction in kidney inflammation among participants. Study: Semaglutide in patients with overweight or obesity and chronic ...

Researchers have discovered that semaglutide, a diabetes and weight-loss medication sold under the brand names Wegovy and Ozempic, might significantly reduce the risk of Alzheimer’s in type 2 diabetes ...

The "About Damn Time" singer shared pics of herself in costume Oct. 26, a month after she brushed off several fans' allegations that she used Ozempic to achieve the slimmer figure she had recently ...

Rybelsus is an oral glucagon-like peptide-1 (GLP-1) agonist and sibling medication to Ozempic and Wegovy. Per a phase 3 trial, Rybelsus was found to reduce cardiovascular risk among patients with ...